Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 747.00K | $ 922.18K | $ 713.92K | $ 891.77K | $ 206.31K |
Total Assets | $ 19.03M | $ 19.04M | $ 18.15M | $ 20.73M | $ 15.91M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 4.33M | $ 4.72M | $ 4.49M | $ 4.32M | $ 4.24M |
Stockholders Equity | $ 14.71M | $ 14.32M | $ 13.65M | $ 16.41M | $ 11.67M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |